Early-Stage TNBC: What are the Roles of PARPIs?

Explore the latest groundbreaking treatment approaches for early-stage triple-negative breast cancer (TNBC) in this engaging tumor board! The multidisciplinary panel of expert faculty will dive into a case involving a patient with early TNBC and discuss the latest data and potential roles of PARP inhibitors (PARPIs) in the first CME activity offered in this TNBC series.
Educational Partner: The Academy for Continued Healthcare Learning (ACHL)

Medium: Online Presentation

Commercial Support: Support for this activity has been provided through educational grants from Gilead Sciences Inc.

Sponsored by the University of Chicago Pritzker School of Medicine and the Academy for Continued Healthcare Learning (ACHL).

Target Audience

This activity is intended for medical oncologists, surgical oncologists, oncology nurses, and other healthcare providers who care for patients with TNBC.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Discuss new targeted treatment approaches in the setting of triple-negative breast cancer;
  • Assess the current evidence and treatment recommendations with the PARPIs for TNBC;
  • Implement strategies to facilitate the use of novel therapies for TNBC in community-based settings.
Additional information
ACGME/ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Tyescia Jackson
CME Coordinator Contact Email: 
Available credit: 
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Participation
Activity opens: 
Activity expires: 
Sarah Blair, MD
Professor and Vice-Chair
UC San Diego Health
San Diego, CA
Sarah Donahue, MPH, NP, AOCNP
Breast Oncology Nurse Practitioner
Breast Cancer Center
UCSF Medical Center
San Francisco, CA
Amir Momeni-Boroujeni, MD
Assistant Attending Pathologist L1
Memorial Sloan Kettering Cancer Center
New York, NY
Rita Nanda, MD
Associate Professor of Medicine
Director, Breast Oncology Program
The University of Chicago Medicine
Chicago, IL

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone in a position to control the content of an education activity to disclose all financial relationships with any ineligible companies. This includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Financial relationships are relevant if a financial relationship, in any amount, exists between the person in control of content and an ineligible company during the past 24 months, and the content of the education is related to the products of an ineligible company with whom the person has a financial relationship. Mechanisms are in place to identify and mitigate any relevant financial relationships prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content.

Physician Credit
The University of Chicago Pritzker School of Medicine Center is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The University Of Chicago Pritzker School Of Medicine designates this enduring material for a maximum of .50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board.
Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.
Registration: To view this activity, you will need to visit ACHL's website.
Click here to view the activity or if you are logged in click on the "Complete Activity" button!
Please login or create an account to proceed.